-
1
-
-
0027355342
-
Etiology of melanoma
-
Koh HK, Sinks TH, Geller AC, Miller DR and Lew RA: Etiology of melanoma. Cancer Treat Res 65: 1-28, 1993.
-
(1993)
Cancer Treat Res
, vol.65
, pp. 1-28
-
-
Koh, H.K.1
Sinks, T.H.2
Geller, A.C.3
Miller, D.R.4
Lew, R.A.5
-
2
-
-
0026470235
-
The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients
-
Haffner AC, Garbe C, Burg G, Buttner P, Orfanos CE and Rassncr G: The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer 66: 856-861, 1992.
-
(1992)
Br J Cancer
, vol.66
, pp. 856-861
-
-
Haffner, A.C.1
Garbe, C.2
Burg, G.3
Buttner, P.4
Orfanos, C.E.5
Rassncr, G.6
-
3
-
-
0024543677
-
Current therapy for malignant melanoma
-
Lcgha SS: Current therapy for malignant melanoma. Semin Oncol 16: 534-344, 1989.
-
(1989)
Semin Oncol
, vol.16
, pp. 534-1344
-
-
Lcgha, S.S.1
-
4
-
-
0026528625
-
Combined treatment of metastatic melanoma with interferons and cytotoxic drugs
-
Garbe C, Kreuser ED, Zouboulis CC, Stadier R and Orfanos CE: Combined treatment of metastatic melanoma with interferons and cytotoxic drugs. Semin Oncol 19: S63-S69, 1992.
-
(1992)
Semin Oncol
, vol.19
-
-
Garbe, C.1
Kreuser, E.D.2
Zouboulis, C.C.3
Stadier, R.4
Orfanos, C.E.5
-
5
-
-
0027315222
-
Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials
-
Keilholz U, Scheibenbogen C, Tilgen W, Bergmann L, Weidmann E, Seither E, Richter M, Brado B, Mitrou PS and Hunstein W: Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials Cancer 72: 607-614, 1993.
-
(1993)
Cancer
, vol.72
, pp. 607-614
-
-
Keilholz, U.1
Scheibenbogen, C.2
Tilgen, W.3
Bergmann, L.4
Weidmann, E.5
Seither, E.6
Richter, M.7
Brado, B.8
Mitrou, P.S.9
Hunstein, W.10
-
6
-
-
0030030347
-
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncolosy Group Trial EST 1684
-
Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC and Blum RH: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncolosy Group Trial EST 1684. J Clin Oncol 14: 7-17, 1996.
-
(1996)
J Clin Oncol
, vol.14
, pp. 7-17
-
-
Kirkwood, J.M.1
Strawderman, M.H.2
Ernstoff, M.S.3
Smith, T.J.4
Borden, E.C.5
Blum, R.H.6
-
7
-
-
0028872965
-
A multicenter phase II clinical trial using dacarbazine and continuous infusion of interleukin-2 in metastatic melanoma: Clinical data and immunomonitorinc
-
Dummer R, Gore M, Hancock B, Guillou P, Grobben H, Becker J, Oskam R, Dieleman J and Burg G: A multicenter phase II clinical trial using dacarbazine and continuous infusion of interleukin-2 in metastatic melanoma: clinical data and immunomonitorinc. Cancer 75: 1038-1044, 1995.
-
(1995)
Cancer
, vol.75
, pp. 1038-1044
-
-
Dummer, R.1
Gore, M.2
Hancock, B.3
Guillou, P.4
Grobben, H.5
Becker, J.6
Oskam, R.7
Dieleman, J.8
Burg, G.9
-
8
-
-
0025837770
-
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malicnant melanoma
-
Falkson CI, Falkson G and Falkson HC: Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malicnant melanoma. J Clin Oncol 9: 1403-1408, 1991.
-
(1991)
J Clin Oncol
, vol.9
, pp. 1403-1408
-
-
Falkson, C.I.1
Falkson, G.2
Falkson, H.C.3
-
9
-
-
0027395732
-
Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines
-
Zakut R, Topalian SL, Kawakami Y, Mancini M, Eliyahu S and Rosenberg SA: Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines. Cancer Res 53: 5-8, 1993.
-
(1993)
Cancer Res
, vol.53
, pp. 5-8
-
-
Zakut, R.1
Topalian, S.L.2
Kawakami, Y.3
Mancini, M.4
Eliyahu, S.5
Rosenberg, S.A.6
-
10
-
-
0027958312
-
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumorinfiltrating lymphocytes
-
Bakker AB, Schreurs MW, De BA, Kawakami Y, Rosenberg SA, Adema GJ and Figdor CG: Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumorinfiltrating lymphocytes. J Exp Med 179: 1005-1009, 1994.
-
(1994)
J Exp Med
, vol.179
, pp. 1005-1009
-
-
Bakker, A.B.1
Schreurs, M.W.2
De, B.A.3
Kawakami, Y.4
Rosenberg, S.A.5
Adema, G.J.6
Figdor, C.G.7
-
11
-
-
0028316911
-
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
-
Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T and Rosenberg SA: Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 91: 3515-3519, 1994.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 3515-3519
-
-
Kawakami, Y.1
Eliyahu, S.2
Delgado, C.H.3
Robbins, P.F.4
Rivoltini, L.5
Topalian, S.L.6
Miki, T.7
Rosenberg, S.A.8
-
12
-
-
0028347940
-
Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
-
Wolfel T, van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Buschenfelde KH and Boon T: Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 24: 759-764, 1994.
-
(1994)
Eur J Immunol
, vol.24
, pp. 759-764
-
-
Wolfel, T.1
Van Pel, A.2
Brichard, V.3
Schneider, J.4
Seliger, B.5
Meyer Zum Buschenfelde, K.H.6
Boon, T.7
-
13
-
-
0030472678
-
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
-
Wang RF, Appella E, Kawakami Y, Kang X and Rosenberg SA: Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med 184: 2207-2216, 1996.
-
(1996)
J Exp Med
, vol.184
, pp. 2207-2216
-
-
Wang, R.F.1
Appella, E.2
Kawakami, Y.3
Kang, X.4
Rosenberg, S.A.5
-
14
-
-
0028239376
-
Loss of HLA haplotype and B locus down-regulation in melanoma cell lines
-
Marincola FM, Shamamian P, Alexander RB, Gnarra JR, Turetskaya RL, Nedospasov SA, Simonis TB, Taubenberger JK, Yannelli J, Mixon A, et al: Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J Immunol 153: 1225-1237, 1994.
-
(1994)
J Immunol
, vol.153
, pp. 1225-1237
-
-
Marincola, F.M.1
Shamamian, P.2
Alexander, R.B.3
Gnarra, J.R.4
Turetskaya, R.L.5
Nedospasov, S.A.6
Simonis, T.B.7
Taubenberger, J.K.8
Yannelli, J.9
Mixon, A.10
-
15
-
-
0029057043
-
Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance
-
Ferrone S and Marincola FM: Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 16:487-494, 1995.
-
(1995)
Immunol Today
, vol.16
, pp. 487-494
-
-
Ferrone, S.1
Marincola, F.M.2
-
16
-
-
0023907034
-
Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma
-
Van Duinen SG, Ruiter DJ, Broecker EB, van der Velde EA, Sorg C, Welvaart K and Ferrone S: Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res 48: 1019-1025, 1988.
-
(1988)
Cancer Res
, vol.48
, pp. 1019-1025
-
-
Van Duinen, S.G.1
Ruiter, D.J.2
Broecker, E.B.3
Van Der Velde, E.A.4
Sorg, C.5
Welvaart, K.6
Ferrone, S.7
-
17
-
-
0031080901
-
Implications for immunosurveillance of altered HLA-class I phenotypes in human tumors
-
Garrido F, Ruiz-Caballo F, Cabrera T, Pérez-Villar JJ, Lopez-Botet M, Duggan-Keen M and Stern PL: Implications for immunosurveillance of altered HLA-class I phenotypes in human tumors. Immunol Today 18: 89-95, 1997.
-
(1997)
Immunol Today
, vol.18
, pp. 89-95
-
-
Garrido, F.1
Ruiz-Caballo, F.2
Cabrera, T.3
Pérez-Villar, J.J.4
Lopez-Botet, M.5
Duggan-Keen, M.6
Stern, P.L.7
-
18
-
-
0025971498
-
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression
-
D'Urso CM, Wang ZG, Cao Y, Tatakc R, Zcff RA and Ferrone S: Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J Clin Invest 87:284-292, 1991.
-
(1991)
J Clin Invest
, vol.87
, pp. 284-292
-
-
D'Urso, C.M.1
Wang, Z.G.2
Cao, Y.3
Tatakc, R.4
Zcff, R.A.5
Ferrone, S.6
-
19
-
-
0027439697
-
Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA
-
Wang Z, Cao Y, Albino AP, Zeff RA, Houghton A and Ferrone S: Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA. J Clin Invest 91: 684-692, 1993.
-
(1993)
J Clin Invest
, vol.91
, pp. 684-692
-
-
Wang, Z.1
Cao, Y.2
Albino, A.P.3
Zeff, R.A.4
Houghton, A.5
Ferrone, S.6
-
20
-
-
0025814580
-
Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene
-
Maio M, Altomonte M, Tatake R, Zeff RA and Ferrone S: Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene. J Clin Invest 88: 282-289, 1991.
-
(1991)
J Clin Invest
, vol.88
, pp. 282-289
-
-
Maio, M.1
Altomonte, M.2
Tatake, R.3
Zeff, R.A.4
Ferrone, S.5
-
21
-
-
0026691106
-
NK cells and T cells: Mirror imaces?
-
Versteeg R: NK cells and T cells: mirror imaces? Immunol Today 13: 244-247, 1992.
-
(1992)
Immunol Today
, vol.13
, pp. 244-247
-
-
Versteeg, R.1
-
22
-
-
0028352305
-
Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours
-
Cromme FV, van Bommel PF, Walboomers JM, Gallee MP, Stern PL, Kenemans P, Heimerhorst TJ, Stukart MJ and Meijer CJ: Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Cancer 69: 1176-1181, 1994.
-
(1994)
Br J Cancer
, vol.69
, pp. 1176-1181
-
-
Cromme, F.V.1
Van Bommel, P.F.2
Walboomers, J.M.3
Gallee, M.P.4
Stern, P.L.5
Kenemans, P.6
Heimerhorst, T.J.7
Stukart, M.J.8
Meijer, C.J.9
-
23
-
-
0029092528
-
Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression
-
Kcating PJ, Cromme FV, Duggan-Keen M, Snijders PJ, Walboomers JM, Hunter RD, Dyer PA and Stern PL: Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br J Cancer 72: 405-411, 1995.
-
(1995)
Br J Cancer
, vol.72
, pp. 405-411
-
-
Kcating, P.J.1
Cromme, F.V.2
Duggan-Keen, M.3
Snijders, P.J.4
Walboomers, J.M.5
Hunter, R.D.6
Dyer, P.A.7
Stern, P.L.8
-
24
-
-
0030891643
-
Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines
-
Thor Strafen P, Kirkin AF, Seremet T and Zeuthen J: Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines. Int J Cancer 70: 582-586, 1997.
-
(1997)
Int J Cancer
, vol.70
, pp. 582-586
-
-
Thor Strafen, P.1
Kirkin, A.F.2
Seremet, T.3
Zeuthen, J.4
-
25
-
-
0027235705
-
Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens
-
Kageshita T, Wang Z, Calorini L, Yoshii A, Kimura T, Ono T, Gattoni-Celli S and Ferrone S: Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res 53: 3349-3354, 1993.
-
(1993)
Cancer Res
, vol.53
, pp. 3349-3354
-
-
Kageshita, T.1
Wang, Z.2
Calorini, L.3
Yoshii, A.4
Kimura, T.5
Ono, T.6
Gattoni-Celli, S.7
Ferrone, S.8
-
26
-
-
0030020784
-
Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma
-
Luboldt HJ, Kubens BS, Rubben H and Grosse-Wilde H: Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma. Cancer Res 56: 826-830, 1996.
-
(1996)
Cancer Res
, vol.56
, pp. 826-830
-
-
Luboldt, H.J.1
Kubens, B.S.2
Rubben, H.3
Grosse-Wilde, H.4
-
27
-
-
0029061997
-
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes
-
Rivoltini L, Barracchini KC, Viggiano V, Kawakami Y, Smith A, Mixon A, Restifo NP, Topalian SL, Simonis TB, Rosenberg SA, et al: Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res 55: 3149-3157, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 3149-3157
-
-
Rivoltini, L.1
Barracchini, K.C.2
Viggiano, V.3
Kawakami, Y.4
Smith, A.5
Mixon, A.6
Restifo, N.P.7
Topalian, S.L.8
Simonis, T.B.9
Rosenberg, S.A.10
-
29
-
-
0031963115
-
Comparative analysis of the in vivo expression of tyrosinase, Mart-1/Melan-a, and gp100 in metastatic melanoma lesions - Implications for immunotherapy
-
Cormier JN, Abati A, Fetsch P, Hijazi YM, Rosenberg SA, Marincola FM and Topalian SL: Comparative analysis of the in vivo expression of tyrosinase, Mart-1/Melan-a, and gp100 in metastatic melanoma lesions - implications for immunotherapy. J Immunother 21: 27-31, 1998.
-
(1998)
J Immunother
, vol.21
, pp. 27-31
-
-
Cormier, J.N.1
Abati, A.2
Fetsch, P.3
Hijazi, Y.M.4
Rosenberg, S.A.5
Marincola, F.M.6
Topalian, S.L.7
-
30
-
-
2642601105
-
Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo
-
Cormier JN, Hijazi YM, Abati A, Fetsch P, Bettinotti M, Stcinberg SM, Rosenberg SA and Marincola FM: Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Int J Cancer 75: 517-524, 1998.
-
(1998)
Int J Cancer
, vol.75
, pp. 517-524
-
-
Cormier, J.N.1
Hijazi, Y.M.2
Abati, A.3
Fetsch, P.4
Bettinotti, M.5
Stcinberg, S.M.6
Rosenberg, S.A.7
Marincola, F.M.8
-
31
-
-
1842372075
-
Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
-
Jäger E, Ringhoffer M, Altmannsberger M, Arand M, Karbach J, Jäger D, Oesch F and Knuth A: Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int J Cancer 71: 142-147, 1997.
-
(1997)
Int J Cancer
, vol.71
, pp. 142-147
-
-
Jäger, E.1
Ringhoffer, M.2
Altmannsberger, M.3
Arand, M.4
Karbach, J.5
Jäger, D.6
Oesch, F.7
Knuth, A.8
-
32
-
-
0029979997
-
+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes
-
+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J Exp Med 183: 1965-1971, 1996.
-
(1996)
J Exp Med
, vol.183
, pp. 1965-1971
-
-
Topalian, S.L.1
Gonzales, M.I.2
Parkhurst, M.3
Li, Y.F.4
Southwood, S.5
Seite, A.6
Rosenberg, S.A.7
Robbins, P.F.8
-
33
-
-
0031660839
-
Higher frequency of selective losses of HLA-A and -B allospecificities in metastases than in primary melanoma lesions
-
Geertsen R, Hofbauer G, Yue F-Y, Burg G and Dummer R: Higher frequency of selective losses of HLA-A and -B allospecificities in metastases than in primary melanoma lesions. J Invest Dermatol 111: 497-502, 1998.
-
(1998)
J Invest Dermatol
, vol.111
, pp. 497-502
-
-
Geertsen, R.1
Hofbauer, G.2
Yue, F.-Y.3
Burg, G.4
Dummer, R.5
-
34
-
-
0029095658
-
C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically
-
Griffioen M, Peltenburg LT, van Oorschot DA and Schrier PI: C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically. Immunobiolocy 193: 238-247, 1995.
-
(1995)
Immunobiolocy
, vol.193
, pp. 238-247
-
-
Griffioen, M.1
Peltenburg, L.T.2
Van Oorschot, D.A.3
Schrier, P.I.4
-
35
-
-
0030048081
-
A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes
-
Brichard VG, Herman J, van Pel A, Wildmann C, Gaugier B, Wolfel T, Boon T and Lethe B: A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur J Immunol 26: 224-230, 1996.
-
(1996)
Eur J Immunol
, vol.26
, pp. 224-230
-
-
Brichard, V.G.1
Herman, J.2
Van Pel, A.3
Wildmann, C.4
Gaugier, B.5
Wolfel, T.6
Boon, T.7
Lethe, B.8
-
36
-
-
0029852657
-
Characterization of antigcnic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3
-
Fleischhauer K, Fruci D, van Endert P, Herman J, Tanzarella S, Wallny HJ, Coulie P, Bordignon C and Traversari C: Characterization of antigcnic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3. Int J Cancer 68: 622-628, 1996.
-
(1996)
Int J Cancer
, vol.68
, pp. 622-628
-
-
Fleischhauer, K.1
Fruci, D.2
Van Endert, P.3
Herman, J.4
Tanzarella, S.5
Wallny, H.J.6
Coulie, P.7
Bordignon, C.8
Traversari, C.9
-
37
-
-
0029875680
-
A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3
-
Herman J, van der Bruggen P, Luescher IF, Mandruzzato S, Romero P, Thonnard J, Fleischhauer K, Boon T and Coulie PG: A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics 43: 377-383, 1996.
-
(1996)
Immunogenetics
, vol.43
, pp. 377-383
-
-
Herman, J.1
Van Der Bruggen, P.2
Luescher, I.F.3
Mandruzzato, S.4
Romero, P.5
Thonnard, J.6
Fleischhauer, K.7
Boon, T.8
Coulie, P.G.9
-
38
-
-
0028358609
-
The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes
-
Liischer U, Filgueira L, Juretic A, Zuber M, Lüscher NJ, Heberer M and Spagnoli GC: The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int J Cancer 57: 612-619, 1994.
-
(1994)
Int J Cancer
, vol.57
, pp. 612-619
-
-
Liischer, U.1
Filgueira, L.2
Juretic, A.3
Zuber, M.4
Lüscher, N.J.5
Heberer, M.6
Spagnoli, G.C.7
-
39
-
-
0029997742
-
Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
-
Jaeger E, Bernhard H, Romero P, Ringhoffer M, Arand M, Karbach J, Ilsemann C, Hagedorn M and Knuth A: Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 66: 162-169, 1996.
-
(1996)
Int J Cancer
, vol.66
, pp. 162-169
-
-
Jaeger, E.1
Bernhard, H.2
Romero, P.3
Ringhoffer, M.4
Arand, M.5
Karbach, J.6
Ilsemann, C.7
Hagedorn, M.8
Knuth, A.9
-
40
-
-
0031941423
-
Vaccination of melanoma patients with peptide- Or tumor lysate-pulsed dendritic cells
-
Nestle FO, Alijagic S, Gilliet M, Sun YS, Grabbe S, Dummer R, Burg G and Schadendorf D: Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4: 328-332, 1998.
-
(1998)
Nat Med
, vol.4
, pp. 328-332
-
-
Nestle, F.O.1
Alijagic, S.2
Gilliet, M.3
Sun, Y.S.4
Grabbe, S.5
Dummer, R.6
Burg, G.7
Schadendorf, D.8
-
41
-
-
0030248766
-
Peptide antigen production by the proteasome: Complexity provides efficiency
-
Groettrup M, Soza A, Kuckelkorn U and Kloetzel PM: Peptide antigen production by the proteasome: complexity provides efficiency. Immunol Today 17: 429-435, 1996.
-
(1996)
Immunol Today
, vol.17
, pp. 429-435
-
-
Groettrup, M.1
Soza, A.2
Kuckelkorn, U.3
Kloetzel, P.M.4
-
42
-
-
0026600786
-
Subunit stoichiometry and three-dimensional arrangement in proteasomes from Thermoplasma acidophihun
-
Puhler G, Weinkauf S, Bachmann L, Muller S, Engel A, Hegerl R and Baumeister W: Subunit stoichiometry and three-dimensional arrangement in proteasomes from Thermoplasma acidophihun. EMBO J 11: 1607-1616, 1992.
-
(1992)
EMBO J
, vol.11
, pp. 1607-1616
-
-
Puhler, G.1
Weinkauf, S.2
Bachmann, L.3
Muller, S.4
Engel, A.5
Hegerl, R.6
Baumeister, W.7
-
43
-
-
0027392566
-
Evidence indicating that the human proteasome is a complex dimer
-
Kopp F, Dahlmann B and Hendil KB: Evidence indicating that the human proteasome is a complex dimer. J Mol Biol 229: 14-19, 1993.
-
(1993)
J Mol Biol
, vol.229
, pp. 14-19
-
-
Kopp, F.1
Dahlmann, B.2
Hendil, K.B.3
-
44
-
-
0025886546
-
Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes
-
Brown MG, Driscoll J and Monaco JJ: Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 353: 355-357, 1991.
-
(1991)
Nature
, vol.353
, pp. 355-357
-
-
Brown, M.G.1
Driscoll, J.2
Monaco, J.J.3
-
45
-
-
0030945333
-
Proteasomes and antisen processing
-
Tanaka K, Tanahashi N, Tsurumi C, Yokota KY and Shimbara N: Proteasomes and antisen processing. Adv Immunol 64: 1-38, 1997.
-
(1997)
Adv Immunol
, vol.64
, pp. 1-38
-
-
Tanaka, K.1
Tanahashi, N.2
Tsurumi, C.3
Yokota, K.Y.4
Shimbara, N.5
-
46
-
-
0027223877
-
MHC-linkcd LMP gene products specifically alter peptidase activities of the proteasome
-
Driscoll J, Brown MG, Finley D and Monaco JJ: MHC-linkcd LMP gene products specifically alter peptidase activities of the proteasome. Nature 365: 262-264, 1993.
-
(1993)
Nature
, vol.365
, pp. 262-264
-
-
Driscoll, J.1
Brown, M.G.2
Finley, D.3
Monaco, J.J.4
-
47
-
-
0025751612
-
Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II recion
-
Bahram S, Arnold D, Brcsnahan M, Strominger JL and Spies T: Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II recion. Proc Natl Acad Sci USA 88: 10094-10098, 1991.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 10094-10098
-
-
Bahram, S.1
Arnold, D.2
Brcsnahan, M.3
Strominger, J.L.4
Spies, T.5
-
48
-
-
0026602751
-
Allelic variants of the human putative peptide transporter involved in antigen processing
-
Colonna M, Bresnahan M, Bahram S, Strominger JL and Spies T: Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci USA 89: 3932-3936, 1992.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 3932-3936
-
-
Colonna, M.1
Bresnahan, M.2
Bahram, S.3
Strominger, J.L.4
Spies, T.5
-
49
-
-
0025604835
-
A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway
-
Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D and De Mars R: A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348: 744-747, 1990.
-
(1990)
Nature
, vol.348
, pp. 744-747
-
-
Spies, T.1
Bresnahan, M.2
Bahram, S.3
Arnold, D.4
Blanck, G.5
Mellins, E.6
Pious, D.7
De Mars, R.8
-
50
-
-
0027548728
-
The transporters associated with antigen presentation
-
Townsend A and Trowsdale J: The transporters associated with antigen presentation. Semin Cell Biol 4: 53-61, 1993.
-
(1993)
Semin Cell Biol
, vol.4
, pp. 53-61
-
-
Townsend, A.1
Trowsdale, J.2
-
51
-
-
0028318838
-
Downregulation of peptide transporter genes in cell lines transformed with the hichly oncogenic adenovirus 12
-
Rotem Yehudar R, Winograd S, Sela S, Coligan JE and Ehrlich R: Downregulation of peptide transporter genes in cell lines transformed with the hichly oncogenic adenovirus 12. J Exp Med 180: 477-488, 1994.
-
(1994)
J Exp Med
, vol.180
, pp. 477-488
-
-
Rotem Yehudar, R.1
Winograd, S.2
Sela, S.3
Coligan, J.E.4
Ehrlich, R.5
-
52
-
-
0030061067
-
Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer
-
Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL and Gatter KC: Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br J Cancer 73: 148-153, 1996.
-
(1996)
Br J Cancer
, vol.73
, pp. 148-153
-
-
Korkolopoulou, P.1
Kaklamanis, L.2
Pezzella, F.3
Harris, A.L.4
Gatter, K.C.5
-
53
-
-
0028094647
-
Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer
-
Kaklamanis L, Townsend A, Doussis Anagnostopoulou IA, Mortensen N, Harris AL and Gatter KC: Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 145: 505-509, 1994.
-
(1994)
Am J Pathol
, vol.145
, pp. 505-509
-
-
Kaklamanis, L.1
Townsend, A.2
Doussis Anagnostopoulou, I.A.3
Mortensen, N.4
Harris, A.L.5
Gatter, K.C.6
-
54
-
-
0028789344
-
Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer
-
Kaklamanis L, Leek R, Koukourakis M, Gatter KC and Harris AL: Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res 55: 5191-5194, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 5191-5194
-
-
Kaklamanis, L.1
Leek, R.2
Koukourakis, M.3
Gatter, K.C.4
Harris, A.L.5
-
55
-
-
0029794179
-
Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing
-
Hicklin DJ, Kageshita T and Ferrone S: Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing. Tissue Antigens 48: 38-46, 1996.
-
(1996)
Tissue Antigens
, vol.48
, pp. 38-46
-
-
Hicklin, D.J.1
Kageshita, T.2
Ferrone, S.3
-
56
-
-
0027980103
-
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
-
Gaugler B, van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethe B, Brasseur F and Boon T: Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179: 921-930, 1994.
-
(1994)
J Exp Med
, vol.179
, pp. 921-930
-
-
Gaugler, B.1
Van Den Eynde, B.2
Van Der Bruggen, P.3
Romero, P.4
Gaforio, J.J.5
De Plaen, E.6
Lethe, B.7
Brasseur, F.8
Boon, T.9
-
57
-
-
0028952240
-
BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
-
Bocl P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T and van der Bruggen P: BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2: 167-175, 1995.
-
(1995)
Immunity
, vol.2
, pp. 167-175
-
-
Bocl, P.1
Wildmann, C.2
Sensi, M.L.3
Brasseur, R.4
Renauld, J.C.5
Coulie, P.6
Boon, T.7
Van Der Bruggen, P.8
-
58
-
-
0029085917
-
A new family of genes coding for an antigen recoenized by autolocous cytolytic T lymphocytes on a human melanoma
-
Van den Eynde B, Peelers O, De Backer O, Gaugier B, Lucas S and Boon T: A new family of genes coding for an antigen recoenized by autolocous cytolytic T lymphocytes on a human melanoma. J Exp Med 182: 689-698, 1995.
-
(1995)
J Exp Med
, vol.182
, pp. 689-698
-
-
Van Den Eynde, B.1
Peelers, O.2
De Backer, O.3
Gaugier, B.4
Lucas, S.5
Boon, T.6
-
59
-
-
2642683198
-
Simultaneous humoral and cellular immune response against cancer-testis antigen Ny-Eso-1 - Definition of human histocompatibility leukocyte antieen (Hla)-A2-bindins: Peptide epitopcs
-
Jaeger E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jager D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ and Knuth A: Simultaneous humoral and cellular immune response against cancer-testis antigen Ny-Eso-1 - definition of human histocompatibility leukocyte antieen (Hla)-A2-bindins: peptide epitopcs. J Exp Med 187: 265-270; 1998.
-
(1998)
J Exp Med
, vol.187
, pp. 265-270
-
-
Jaeger, E.1
Chen, Y.T.2
Drijfhout, J.W.3
Karbach, J.4
Ringhoffer, M.5
Jager, D.6
Arand, M.7
Wada, H.8
Noguchi, Y.9
Stockert, E.10
Old, L.J.11
Knuth, A.12
-
61
-
-
0031688307
-
Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA
-
Hofbauer G, Dummer R, Laine E and Burg G: Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA. Arch Dermatol Res 290: 458-461, 1998.
-
(1998)
Arch Dermatol Res
, vol.290
, pp. 458-461
-
-
Hofbauer, G.1
Dummer, R.2
Laine, E.3
Burg, G.4
-
62
-
-
0029069090
-
Identification and intracellular location of MAGE-3 gene product
-
Kocher T, Schultz-Thater E, Gudat F, Schaefer C, Casorati G, Juretic A, Willimann T, Harder F, Heberer M and Spagnoli GC: Identification and intracellular location of MAGE-3 gene product. Cancer Res 55: 2236-2239, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 2236-2239
-
-
Kocher, T.1
Schultz-Thater, E.2
Gudat, F.3
Schaefer, C.4
Casorati, G.5
Juretic, A.6
Willimann, T.7
Harder, F.8
Heberer, M.9
Spagnoli, G.C.10
-
63
-
-
0030699528
-
Mage-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma - Frequency and distribution
-
Hofbauer GFL, Schaefer C, Noppen C, Böni R, Kamarashcv J, Nestle FO, Spagnoli GC and Dummer R: Mage-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma - frequency and distribution. Am J Pathol 151: 1549-1553, 1997.
-
(1997)
Am J Pathol
, vol.151
, pp. 1549-1553
-
-
Hofbauer, G.F.L.1
Schaefer, C.2
Noppen, C.3
Böni, R.4
Kamarashcv, J.5
Nestle, F.O.6
Spagnoli, G.C.7
Dummer, R.8
-
64
-
-
0028906594
-
Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes
-
(published erratum appears in J Exp Med 181: 1261, 1995).
-
Wang RF, Robbins PF, Kawakami Y, Kang XQ and Rosenberg SA: Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes (published erratum appears in J Exp Med 181: 1261, 1995). J Exp Med 181:799-804, 1995.
-
(1995)
J Exp Med
, vol.181
, pp. 799-804
-
-
Wang, R.F.1
Robbins, P.F.2
Kawakami, Y.3
Kang, X.Q.4
Rosenberg, S.A.5
-
65
-
-
0030996710
-
Enhancement of cellular immunity in melanoma patients immunized with a peptidc from MART-1/Melan a
-
Cormier JN, Salgaller ML, Prevette T, Barracchini KC, Rivoltini L, Restifo NP, Rosenberg SA and Marincola FM: Enhancement of cellular immunity in melanoma patients immunized with a peptidc from MART-1/Melan A (see comments). Cancer J Sci Am 3: 37-44, 1997.
-
(1997)
Cancer J Sci Am
, vol.3
, pp. 37-44
-
-
Cormier, J.N.1
Salgaller, M.L.2
Prevette, T.3
Barracchini, K.C.4
Rivoltini, L.5
Restifo, N.P.6
Rosenberg, S.A.7
Marincola, F.M.8
-
66
-
-
0029114633
-
Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development
-
Chen YT, Stocken E, Tsang S, Coplan KA and Old LJ: Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci USA 92: 8125-8129, 1995.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 8125-8129
-
-
Chen, Y.T.1
Stocken, E.2
Tsang, S.3
Coplan, K.A.4
Old, L.J.5
-
67
-
-
0031956632
-
Tyrosinase immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: Frequency and distribution
-
Hofbauer G, Kamarashcv J, Gecrtsen R, Böni R and Dummer R: Tyrosinase immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. J Cutan Pathol 25: 204-209, 1998.
-
(1998)
J Cutan Pathol
, vol.25
, pp. 204-209
-
-
Hofbauer, G.1
Kamarashcv, J.2
Gecrtsen, R.3
Böni, R.4
Dummer, R.5
-
68
-
-
0031659143
-
MelanA/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: Frequency and distribution
-
Hofbauer G, Kamarashcv J, Gcertsen R, Böni R and Dummer R: MelanA/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. Melanoma Res 8: 337-343, 1998.
-
(1998)
Melanoma Res
, vol.8
, pp. 337-343
-
-
Hofbauer, G.1
Kamarashcv, J.2
Gcertsen, R.3
Böni, R.4
Dummer, R.5
-
69
-
-
8944254243
-
Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions
-
Marincola FM, Hijazi YM, Fetsch P, Salgaller ML, Rivoltini L, Cormier J, Simonis TB, Duray PH, Herlyn M, Kawakami Y and Rosenberg SA: Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J Immunother Emphasis Tumor Immunol 19: 192-205, 1996.
-
(1996)
J Immunother Emphasis Tumor Immunol
, vol.19
, pp. 192-205
-
-
Marincola, F.M.1
Hijazi, Y.M.2
Fetsch, P.3
Salgaller, M.L.4
Rivoltini, L.5
Cormier, J.6
Simonis, T.B.7
Duray, P.H.8
Herlyn, M.9
Kawakami, Y.10
Rosenberg, S.A.11
-
70
-
-
0028978274
-
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
-
Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankein T, Meyer zum Buschenfelde KH and Beach D: A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269: 1281-1284, 1995.
-
(1995)
Science
, vol.269
, pp. 1281-1284
-
-
Wölfel, T.1
Hauer, M.2
Schneider, J.3
Serrano, M.4
Wölfel, C.5
Klehmann-Hieb, E.6
De Plaen, E.7
Hankein, T.8
Meyer Zum Buschenfelde, K.H.9
Beach, D.10
-
71
-
-
0032549042
-
Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type
-
Akslen LA, Monstad SE, Larsen B, Straume O and Ogreid D: Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. Int J Cancer 79: 91-95, 1998.
-
(1998)
Int J Cancer
, vol.79
, pp. 91-95
-
-
Akslen, L.A.1
Monstad, S.E.2
Larsen, B.3
Straume, O.4
Ogreid, D.5
-
72
-
-
0031905632
-
Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas
-
Gnjatic S, Cai Z, Viguier M, Chouaib S, Guillet JG and Choppin J: Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J Immunol 160: 328-333, 1998.
-
(1998)
J Immunol
, vol.160
, pp. 328-333
-
-
Gnjatic, S.1
Cai, Z.2
Viguier, M.3
Chouaib, S.4
Guillet, J.G.5
Choppin, J.6
-
73
-
-
0030800823
-
A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma
-
Mandruzzato S, Brasseur F, Andry G, Boon T and van der Bruggen P: A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 186: 785-793, 1997.
-
(1997)
J Exp Med
, vol.186
, pp. 785-793
-
-
Mandruzzato, S.1
Brasseur, F.2
Andry, G.3
Boon, T.4
Van Der Bruggen, P.5
-
74
-
-
0030633566
-
HER-2/neu protein: A target for antigen-specific immunotherapy of human cancer
-
Disis ML and Cheever MA: HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer. Adv Cancer Res 71: 343-371, 1997.
-
(1997)
Adv Cancer Res
, vol.71
, pp. 343-371
-
-
Disis, M.L.1
Cheever, M.A.2
-
75
-
-
13344282077
-
Human neoplasms elicit multiple specific immune responses in the autologous host
-
Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuh M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810-11813, 1995.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 11810-11813
-
-
Sahin, U.1
Tureci, O.2
Schmitt, H.3
Cochlovius, B.4
Johannes, T.5
Schmits, R.6
Stenner, F.7
Luo, G.8
Schobert, I.9
Pfreundschuh, M.10
-
76
-
-
0030962059
-
Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
-
Ikeda H, Lethe B, Lehmann F, van Baren N, Baurain JF, De Smet C, Chambost H, Vitale M, Moretta A, Boon T and Coulie PG: Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6: 199-208, 1997.
-
(1997)
Immunity
, vol.6
, pp. 199-208
-
-
Ikeda, H.1
Lethe, B.2
Lehmann, F.3
Van Baren, N.4
Baurain, J.F.5
De Smet, C.6
Chambost, H.7
Vitale, M.8
Moretta, A.9
Boon, T.10
Coulie, P.G.11
-
78
-
-
0027767762
-
Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
-
Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VJ, Lombard LA, Gray GS and Nadler LM: Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262: 909-911, 1993.
-
(1993)
Science
, vol.262
, pp. 909-911
-
-
Freeman, G.J.1
Gribben, J.G.2
Boussiotis, V.A.3
Ng, J.W.4
Restivo, V.J.5
Lombard, L.A.6
Gray, G.S.7
Nadler, L.M.8
-
79
-
-
0029073050
-
B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of 1L-4
-
Freeman GJ, Boussiotis VA, Amimanthan A, Bernstein GM, Kc XY, Renncrt PD, Gray GS, Gribben JG and Nadler LM: B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of 1L-4. Immunity 2: 523-532, 1995.
-
(1995)
Immunity
, vol.2
, pp. 523-532
-
-
Freeman, G.J.1
Boussiotis, V.A.2
Amimanthan, A.3
Bernstein, G.M.4
Kc, X.Y.5
Renncrt, P.D.6
Gray, G.S.7
Gribben, J.G.8
Nadler, L.M.9
-
80
-
-
0027942023
-
Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity
-
Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ and Nadler LM: Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity. Blood 84: 3261-3282, 1994.
-
(1994)
Blood
, vol.84
, pp. 3261-3282
-
-
Guinan, E.C.1
Gribben, J.G.2
Boussiotis, V.A.3
Freeman, G.J.4
Nadler, L.M.5
-
81
-
-
0031463526
-
Is Ctla-4 a necative regulator for T-cell activation
-
Liu Y: Is Ctla-4 a necative regulator for T-cell activation. Immunol Today 18:569-572, 1997.
-
(1997)
Immunol Today
, vol.18
, pp. 569-572
-
-
Liu, Y.1
-
82
-
-
0028223557
-
T-helper- And accessory-cell-independent cytotoxic responses to human tumor cells transfectcd with a B7 retroviral vector
-
Duhring C, Angman L, Spagnoli G and Lanzavecchia A: T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfectcd with a B7 retroviral vector. Int J Cancer 57: 754-759, 1994.
-
(1994)
Int J Cancer
, vol.57
, pp. 754-759
-
-
Duhring, C.1
Angman, L.2
Spagnoli, G.3
Lanzavecchia, A.4
-
83
-
-
0028646191
-
Specificity and longevity of antitumor immune responses induced by B7-transfected tumors
-
Townsend SE, Su FW, Atherton JM and Allison JP: Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res 54: 6477-6483, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 6477-6483
-
-
Townsend, S.E.1
Su, F.W.2
Atherton, J.M.3
Allison, J.P.4
-
84
-
-
0028263666
-
+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma
-
+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J Immunol 153: 421-428, 1994.
-
(1994)
J Immunol
, vol.153
, pp. 421-428
-
-
Li, Y.1
McGowan, P.2
Hellstrom, I.3
Hellstrom, K.E.4
Chen, L.5
-
85
-
-
0029165133
-
In situ expression of B7 and CD28 receptor families in human malignant melanomarelevance for T-cell-mediated anti-tumor immunity
-
Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, Schopf E and Simon JC: In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity. Int J Cancer 62: 259-265, 1995.
-
(1995)
Int J Cancer
, vol.62
, pp. 259-265
-
-
Denfeld, R.W.1
Dietrich, A.2
Wuttig, C.3
Tanczos, E.4
Weiss, J.M.5
Vanscheidt, W.6
Schopf, E.7
Simon, J.C.8
-
86
-
-
0029032151
-
A phase I trial of B7-transfected parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401
-
Fenton RT, Sznol M, Luster DG, Taub DD and Longo DL: A phase I trial of B7-transfected parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401. Hum Gene Ther 6: 87-106, 1995.
-
(1995)
Hum Gene Ther
, vol.6
, pp. 87-106
-
-
Fenton, R.T.1
Sznol, M.2
Luster, D.G.3
Taub, D.D.4
Longo, D.L.5
-
87
-
-
0031942907
-
Immune stimulatory potential of B7-1 and B7-2 retrovirally transduced melanoma cells: Suppression by IL-10
-
Dummer R, Yue F-Y, Pavlovic J, Geertscn R, Döring C, Moelling K and Burg G: Immune stimulatory potential of B7-1 and B7-2 retrovirally transduced melanoma cells: suppression by IL-10. Br J Cancer 77: 1413-1419, 1998.
-
(1998)
Br J Cancer
, vol.77
, pp. 1413-1419
-
-
Dummer, R.1
Yue, F.-Y.2
Pavlovic, J.3
Geertscn, R.4
Döring, C.5
Moelling, K.6
Burg, G.7
-
88
-
-
0028853546
-
A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and alloseneic lymphocytes
-
Sule-Suso J, Arienti F, Melani C, Colombo MP and Parmiani G: A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and alloseneic lymphocytes. Eur J Immunol 25: 2737-2742, 1995.
-
(1995)
Eur J Immunol
, vol.25
, pp. 2737-2742
-
-
Sule-Suso, J.1
Arienti, F.2
Melani, C.3
Colombo, M.P.4
Parmiani, G.5
-
89
-
-
0028949152
-
B7-1 and B7-2 costimulatory molecules activate differentially theTh1/Th2 developmental pathways: Application to autoimmune disease therapy
-
Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N and Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially theTh1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718, 1995.
-
(1995)
Cell
, vol.80
, pp. 707-718
-
-
Kuchroo, V.K.1
Das, M.P.2
Brown, J.A.3
Ranger, A.M.4
Zamvil, S.S.5
Sobel, R.A.6
Weiner, H.L.7
Nabavi, N.8
Glimcher, L.H.9
-
90
-
-
0028819315
-
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL
-
Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D and Azuma M: CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154: 97-105, 1995.
-
(1995)
J Immunol
, vol.154
, pp. 97-105
-
-
Lanier, L.L.1
O'Fallon, S.2
Somoza, C.3
Phillips, J.H.4
Linsley, P.S.5
Okumura, K.6
Ito, D.7
Azuma, M.8
-
91
-
-
0029201083
-
Lymphocyte-melanoma interaction: Role of surface molecules
-
Becker JC and Bröcker EB: Lymphocyte-melanoma interaction: role of surface molecules. Recent Results Cancer Res 139: 205-214, 1995.
-
(1995)
Recent Results Cancer Res
, vol.139
, pp. 205-214
-
-
Becker, J.C.1
Bröcker, E.B.2
-
92
-
-
0027241328
-
Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines
-
Scheibenbogen C, Keilholz U, Meuer S, Dengler T, Tilgen W and Hunstein W: Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines. Int J Cancer 54: 494-498, 1993.
-
(1993)
Int J Cancer
, vol.54
, pp. 494-498
-
-
Scheibenbogen, C.1
Keilholz, U.2
Meuer, S.3
Dengler, T.4
Tilgen, W.5
Hunstein, W.6
-
93
-
-
0026322355
-
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gammruand tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity
-
Becker JC, Dummer R, Hartmann AA, Burg G and Schmidt RE: Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gammruand tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol 147: 4398-4401, 1991.
-
(1991)
J Immunol
, vol.147
, pp. 4398-4401
-
-
Becker, J.C.1
Dummer, R.2
Hartmann, A.A.3
Burg, G.4
Schmidt, R.E.5
-
94
-
-
0028236075
-
Various cytokines modulate ICAM-1 shedding from melanoma and CTCL-derived cell lines: Inverse regulation of ICAM-1 shedding in a Sezary cell line by interferon-gamma
-
Dummer R, Sigg-Zemann S, Kaltoft K, Muletta S, Meyer J and Burg G: Various cytokines modulate ICAM-1 shedding from melanoma and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sezary cell line by interferon-gamma. Dermatology 189: 120-124, 1994.
-
(1994)
Dermatology
, vol.189
, pp. 120-124
-
-
Dummer, R.1
Sigg-Zemann, S.2
Kaltoft, K.3
Muletta, S.4
Meyer, J.5
Burg, G.6
-
95
-
-
0030790353
-
High CD44 surface expression on primary tumours of malicnant melanoma correlates with increased mctastatic risk and reduced survival
-
Dietrich A, Tanczos E, Vanscheidt W, Schopf E and Simon JC: High CD44 surface expression on primary tumours of malicnant melanoma correlates with increased mctastatic risk and reduced survival. Eur J Cancer 33: 926-930, 1997.
-
(1997)
Eur J Cancer
, vol.33
, pp. 926-930
-
-
Dietrich, A.1
Tanczos, E.2
Vanscheidt, W.3
Schopf, E.4
Simon, J.C.5
-
96
-
-
0030030109
-
Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage
-
Schadendorf D, Diehl S, Zuberbie T, Schadendorf C and Henz BM: Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology 192: 89-93, 1996.
-
(1996)
Dermatology
, vol.192
, pp. 89-93
-
-
Schadendorf, D.1
Diehl, S.2
Zuberbie, T.3
Schadendorf, C.4
Henz, B.M.5
-
97
-
-
0030910463
-
Endothelial-selectin ligands sialyl Lcwis(x) and sialyl Lcwis(a) are differentiation antigens immunogcnic in human melanoma
-
Ravindranath MH, Amiri AA, Bauer PM, Kelley MC, Essner R and Morion DL: Endothelial-selectin ligands sialyl Lcwis(x) and sialyl Lcwis(a) are differentiation antigens immunogcnic in human melanoma. Cancer 79: 1686-1697, 1997.
-
(1997)
Cancer
, vol.79
, pp. 1686-1697
-
-
Ravindranath, M.H.1
Amiri, A.A.2
Bauer, P.M.3
Kelley, M.C.4
Essner, R.5
Morion, D.L.6
-
98
-
-
0024408824
-
Two types of mouse T-hclper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
-
Fiorentino DF, Bond MW and Mosmann TR: Two types of mouse T-hclper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081-2095, 1989.
-
(1989)
J Exp Med
, vol.170
, pp. 2081-2095
-
-
Fiorentino, D.F.1
Bond, M.W.2
Mosmann, T.R.3
-
99
-
-
0026570853
-
IL-10 inhibits human T cell proliferation and IL-2 production
-
Taga K and Tosato G: IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148: 1143-1148, 1992.
-
(1992)
J Immunol
, vol.148
, pp. 1143-1148
-
-
Taga, K.1
Tosato, G.2
-
100
-
-
0025111466
-
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce IL-10
-
O'Garra A, Stapleton G, Dhar V, Pearce M, Schumacher J, Hugo H, Barbis D, Stall A, Cupp J, Moore K, Whitmore A, Arnoid L, Haughton G and Howard M: Production of cytokines by mouse B cells: B lymphomas and normal B cells produce IL-10. Int Immunol 2: 821-827, 1990.
-
(1990)
Int Immunol
, vol.2
, pp. 821-827
-
-
O'Garra, A.1
Stapleton, G.2
Dhar, V.3
Pearce, M.4
Schumacher, J.5
Hugo, H.6
Barbis, D.7
Stall, A.8
Cupp, J.9
Moore, K.10
Whitmore, A.11
Arnoid, L.12
Haughton, G.13
Howard, M.14
-
101
-
-
0026721289
-
Identification and induction of keratinocyte-dcrived IL-10
-
Enk AH and Katz SI: Identification and induction of keratinocyte-dcrived IL-10. J Immunol 149: 92-95, 1992.
-
(1992)
J Immunol
, vol.149
, pp. 92-95
-
-
Enk, A.H.1
Katz, S.I.2
-
102
-
-
0025763807
-
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
-
Fiorcntino DF, Zlotnik A, Vieira P, Mosmann TR, Howard W, Moore KW and O'Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146: 3444-3451, 1991.
-
(1991)
J Immunol
, vol.146
, pp. 3444-3451
-
-
Fiorcntino, D.F.1
Zlotnik, A.2
Vieira, P.3
Mosmann, T.R.4
Howard, W.5
Moore, K.W.6
O'Garra, A.7
-
103
-
-
0028966911
-
Elevated serum levels of interleukin-10 in patients with metastatic malicnant melanoma
-
Dummer W, Becker JC, Schwaaf A, Leverkus M, Moll T and Bröcker EB: Elevated serum levels of interleukin-10 in patients with metastatic malicnant melanoma. Melanoma Res 5: 67-68, 1995.
-
(1995)
Melanoma Res
, vol.5
, pp. 67-68
-
-
Dummer, W.1
Becker, J.C.2
Schwaaf, A.3
Leverkus, M.4
Moll, T.5
Bröcker, E.B.6
-
104
-
-
0030950036
-
Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules
-
Yue FY, Dummer R, Geertsen R, Hofbauer G, Laine E, Manolio S and Burg G: Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer 71: 630-637, 1997.
-
(1997)
Int J Cancer
, vol.71
, pp. 630-637
-
-
Yue, F.Y.1
Dummer, R.2
Geertsen, R.3
Hofbauer, G.4
Laine, E.5
Manolio, S.6
Burg, G.7
-
105
-
-
0029888382
-
Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesions
-
Dummer W, Bastian BC, Ernst N, Schänzle C, Schwaaf A and Bröcker EB: Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int J Cancer 66: 607-610, 1996.
-
(1996)
Int J Cancer
, vol.66
, pp. 607-610
-
-
Dummer, W.1
Bastian, B.C.2
Ernst, N.3
Schänzle, C.4
Schwaaf, A.5
Bröcker, E.B.6
-
106
-
-
0027232788
-
+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation
-
+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150:4754-4765, 1993.
-
(1993)
J Immunol
, vol.150
, pp. 4754-4765
-
-
De Waal Malefyt, R.1
Yssel, H.2
De, V.J.3
-
107
-
-
0027959417
-
Interleukin 10 pretreatmcnt protects target cells from tumor- And allo-specific cytotoxic T cells and downregulates HLA class I expression
-
Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG and Kicssling R: Interleukin 10 pretreatmcnt protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180:2371-2376, 1994.
-
(1994)
J Exp Med
, vol.180
, pp. 2371-2376
-
-
Matsuda, M.1
Salazar, F.2
Petersson, M.3
Masucci, G.4
Hansson, J.5
Pisa, P.6
Zhang, Q.J.7
Masucci, M.G.8
Kicssling, R.9
-
108
-
-
0008934205
-
Pathways to programmed cell death: Apoptosis and the skin
-
Haake AR and Polakowska RR: Pathways to programmed cell death: apoptosis and the skin. Curr Opin Dermatol 4: 247-255, 1997.
-
(1997)
Curr Opin Dermatol
, vol.4
, pp. 247-255
-
-
Haake, A.R.1
Polakowska, R.R.2
-
109
-
-
10544232277
-
Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
-
Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J and Tschopp J: Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274: 1363-1366, 1996.
-
(1996)
Science
, vol.274
, pp. 1363-1366
-
-
Hahne, M.1
Rimoldi, D.2
Schroter, M.3
Romero, P.4
Schreier, M.5
French, L.E.6
Schneider, P.7
Bornand, T.8
Fontana, A.9
Lienard, D.10
Cerottini, J.11
Tschopp, J.12
|